Related Experiment Video
Updated: Apr 18, 2026

Induction of Graft-versus-host Disease and In Vivo T Cell Monitoring Using an MHC-matched Murine Model
Published on: August 29, 2012
Grading acute graft-versus-host disease: time to reconsider
Rakesh K Goyal1, Manu Goyal, Kumar Sankaranarayan
1Division of Blood and Marrow Transplantation and Cellular Therapies at Children's Hospital of Pittsburgh of UPMC, Pittsburgh, PA, USA; University of Pittsburgh, Pittsburgh, PA, USA.
Acute graft-versus-host disease (GVHD) poses risks after blood and marrow transplants. This review analyzes scoring ambiguities and proposes improvements for better acute GVHD severity assessment.
Area of Science:
- Hematology
- Immunology
- Transplantation Medicine
Background:
- Acute graft-versus-host disease (GVHD) is a frequent and severe complication following allogeneic blood and marrow transplantation (BMT).
- Current grading systems, such as the modified Glucksberg criteria, exhibit significant heterogeneity within grades.
- Variations in organ involvement (skin, liver, gut) contribute to inconsistencies in severity assessment.
Purpose of the Study:
- To critically review the ambiguities and limitations in current acute GVHD severity scoring systems.
- To propose specific, actionable recommendations for improving acute GVHD grading.
- To stimulate discussion within the BMT community regarding potential refinements and validation of revised scoring methods.
Main Methods:
- Analytical review of existing literature and clinical practices related to acute GVHD grading.
- Identification and categorization of ambiguities within the modified Glucksberg criteria.
- Formulation of proposals for enhanced severity scoring.
Main Results:
- Significant heterogeneity exists within established acute GVHD grades, impacting clinical management and research.
- Current scoring criteria do not fully capture the spectrum of organ-specific involvement and overall disease severity.
- Specific areas of ambiguity in scoring skin, liver, and gut GVHD were identified.
Conclusions:
- Refinement of acute GVHD scoring is necessary to reduce within-grade heterogeneity.
- The proposed analytical framework and specific recommendations aim to foster community consensus and guide future validation studies.
- Improved GVHD severity scoring will enhance clinical decision-making and facilitate more accurate comparisons across studies.
More Related Videos
08:05Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease
Published on: March 17, 2020
06:06Induction and Scoring of Graft-Versus-Host Disease in a Xenogeneic Murine Model and Quantification of Human T Cells in Mouse Tissues using Digital PCR
Published on: May 23, 2019
Related Concept Videos
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Cell-mediated Immune Responses